31 December 2015 - The first issue of the Schedule for the new year sees the listing of two Roche medicines: trastuzumab (HerceptIn) for gastric cancer and rituximab (MabThera) for patients with granulomatosis with polyangiitis or microscopic polyangiitis.

For more details, go to: http://www.pbs.gov.au/browse/changes